Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imvamune for basal cell and squamous cell carcinomas
NCT04410874Phase 2Terminated
- Start
- Nov 2020
- Primary completion
- May 2023
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of JYNNEOS in basal cell carcinoma (BCC), squamous cell carcinoma (SCC). Started Nov 2020; status: terminated.
02
Drugs
JYNNEOS
03
Conditions
basal cell carcinoma (BCC)squamous cell carcinoma (SCC)
Beyond the preview
Go deeper on NCT04410874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04410874.